User:Libby EMAcomm/Working page 2020
Appearance
Here are my edits in 2020, please comment:
Sofosbuvir: 3/2 added recommendation of 2016 review under 'Side effects'
Daclatasvir: 3/2 added recommendation of 2016 review under 'Adverse effects'
Simeprevir: 3/2 added recommendation of 2016 review under 'Adverse effects'
Ombitasvir/paritaprevir/ritonavir: 3/2 added recommendation of 2016 review under 'Side effects'
Ledipasvir/sofosbuvir: 3/2 added recommendation of 2016 review under 'Side effects'
Dasabuvir: 3/2 added recommendation of 2016 review under 'Adverse effects'